EUVIMEDEUVIMED entdecken
Querschnittstudie

Covid-19 Vaccination Uptake Among Remote Communities In Malaysia: A Cross-Sectional Study

Maznieda Mahjom, Imanul Hassan Abdul Shukor, Masita Arip, Fitri Suraya Mohamad Hapni Joblie, Rohaida Ismail, Sahipudin Sarip, Mizanurfakhri Ghazali, Nurul Fadzilah, Zawani Zain, Dzarifah Hanis Md Sairi

International Journal of Telemedicine and Digital Health · 30.07.2026 · 02 (01) · 01-11

DOI: 10.66311/ijtdh.02.01.01 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift International Journal of Telemedicine and Digital Health, online erschienen am 30.07.2026. Verfasst von Maznieda Mahjom und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic outbreak started in Wuhan City, Hubei Province, China, in December 2019 and subsequently spread globally with a 3.4% mortality rate of 87,137 confirmed cases as of March 1, 2020 and currently in February 16, 2024 it caused 0.9% mortality rate of 703,305,215 nationwide confirmed cases [1,2]. The coronavirus disease 2019, or COVID-19, was named the disease by the World Health Organization (WHO) and poses a significant threat to public health, including Malaysia. The virus’s global spread was attributed to sustained human-to-human transmission, leading to exported cases worldwide and WHO announced it as a pandemic on March 11, 2020 [1,3,4]. It is a newly discovered novel strain of coronavirus detected on December 31, 2019 [1]. Utilising the angiotensinconverting enzyme 2 (ACE2) receptor, like SARS-CoV, the virus predominantly spreads through the respiratory tract [5]. Clinical symptoms exhibited by COVID-19 patients included fever, cough, fatigue, and, in some cases, gastrointestinal infection symptoms [6]. Vulnerability to infection and a propensity for severe outcomes, such as acute respiratory distress syndrome (ARDS) and cytokine storms, were observed notably in the elderly and those with underlying diseases [7]. The SARS-CoV-2 was initially treated as secondary and tertiary prevention under the level of disease prevention aiming for early diagnosis from prompt, optimised and sustained care, rehabilitation, and disability prevention [8]. Subsequently, when the virus characteristic was established the prevention level focused on primordial and primary prevention, including the health education, health promotion, new vaccine development and immunisation [8].

Zitieren

APA

Mahjom, M., Shukor, I. H. A., Arip, M., Joblie, F. S. M. H., Ismail, R., Sarip, S., Ghazali, M., Fadzilah, N., Zain, Z., & Sairi, D. H. M. (2026). Covid-19 Vaccination Uptake Among Remote Communities In Malaysia: A Cross-Sectional Study. International Journal of Telemedicine and Digital Health, 02(01), 01-11. https://doi.org/10.66311/ijtdh.02.01.01

Vancouver

Mahjom M, Shukor IHA, Arip M, Joblie FSMH, Ismail R, Sarip S, et al. Covid-19 Vaccination Uptake Among Remote Communities In Malaysia: A Cross-Sectional Study. International Journal of Telemedicine and Digital Health. 2026;02(01):01-11. doi:10.66311/ijtdh.02.01.01

BibTeX
@article{Mahjom2026,
  author = {Mahjom, Maznieda and Shukor, Imanul Hassan Abdul and Arip, Masita and Joblie, Fitri Suraya Mohamad Hapni and Ismail, Rohaida and Sarip, Sahipudin and Ghazali, Mizanurfakhri and Fadzilah, Nurul and Zain, Zawani and Sairi, Dzarifah Hanis Md},
  title = {Covid-19 Vaccination Uptake Among Remote Communities In Malaysia: A Cross-Sectional Study},
  journal = {International Journal of Telemedicine and Digital Health},
  year = {2026},
  volume = {02},
  number = {01},
  pages = {01--11},
  doi = {10.66311/ijtdh.02.01.01}
}
Kostenlos starten →